Natalie L Marchant1, Lise R Lovland1, Rebecca Jones1, Alexa Pichet Binette2,3, Julie Gonneaud2,3, Eider M Arenaza-Urquijo4,5, Gael Chételat4, Sylvia Villeneuve2,3. 1. Division of Psychiatry, University College London, London, United Kingdom. 2. Studies on Prevention of Alzheimer's Disease (StOP-AD) Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada. 3. McGill Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada. 4. Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Cyceron, Caen, 14000, France. 5. Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.
Abstract
INTRODUCTION: The Cognitive Debt hypothesis proposes that repetitive negative thinking (RNT), a modifiable process common to many psychological risk factors for Alzheimer's disease (AD) may itself increase risk. We sought to empirically examine relationships between RNT and markers of AD, compared with anxiety and depression symptoms. METHODS: Two hundred and ninety-two older adults with longitudinal cognitive assessments, including 113 with amyloid-positron emission tomography (PET) and tau-PET scans, from the PREVENT-AD cohort and 68 adults with amyloid-PET scans from the IMAP+ cohort were included. All participants completed RNT, anxiety, and depression questionnaires. RESULTS: RNT was associated with decline in global cognition (P = .02); immediate (P = .03) and delayed memory (P = .04); and global amyloid (PREVENT-AD: P = .01; IMAP+: P = .03) and entorhinal tau (P = .02) deposition. Relationships remained after adjusting for potential confounders. DISCUSSION: RNT was associated with decline in cognitive domains affected early in AD and with neuroimaging AD biomarkers. Future research could investigate whether modifying RNT reduces AD risk.
INTRODUCTION: The Cognitive Debt hypothesis proposes that repetitive negative thinking (RNT), a modifiable process common to many psychological risk factors for Alzheimer's disease (AD) may itself increase risk. We sought to empirically examine relationships between RNT and markers of AD, compared with anxiety and depression symptoms. METHODS: Two hundred and ninety-two older adults with longitudinal cognitive assessments, including 113 with amyloid-positron emission tomography (PET) and tau-PET scans, from the PREVENT-AD cohort and 68 adults with amyloid-PET scans from the IMAP+ cohort were included. All participants completed RNT, anxiety, and depression questionnaires. RESULTS: RNT was associated with decline in global cognition (P = .02); immediate (P = .03) and delayed memory (P = .04); and global amyloid (PREVENT-AD: P = .01; IMAP+: P = .03) and entorhinal tau (P = .02) deposition. Relationships remained after adjusting for potential confounders. DISCUSSION: RNT was associated with decline in cognitive domains affected early in AD and with neuroimaging AD biomarkers. Future research could investigate whether modifying RNT reduces AD risk.
Authors: Mitzi M Gonzales; Jasmeet Samra; Adrienne O'Donnell; R Scott Mackin; Joel Salinas; Mini E Jacob; Claudia L Satizabal; Hugo J Aparicio; Emma G Thibault; Justin S Sanchez; Rebecca Finney; Zoe B Rubinstein; Danielle V Mayblyum; Ron J Killiany; Charlie S Decarli; Keith A Johnson; Alexa S Beiser; Sudha Seshadri Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Helmet T Karim; Maria Ly; Gary Yu; Robert Krafty; Dana L Tudorascu; Howard J Aizenstein; Carmen Andreescu Journal: Neurobiol Aging Date: 2021-01-20 Impact factor: 4.673
Authors: Kathi L Heffner; Maria M Quiñones; Autumn M Gallegos; Hugh F Crean; Feng Lin; Julie A Suhr Journal: Aging Ment Health Date: 2021-03-30 Impact factor: 3.514
Authors: Gabriele Cattaneo; Javier Solana-Sánchez; Kilian Abellaneda-Pérez; Cristina Portellano-Ortiz; Selma Delgado-Gallén; Vanessa Alviarez Schulze; Catherine Pachón-García; H Zetterberg; Jose Maria Tormos; Alvaro Pascual-Leone; David Bartrés-Faz Journal: Front Psychol Date: 2022-03-28
Authors: Ivanna M Pavisic; Kirsty Lu; Sarah E Keuss; Sarah-Naomi James; Christopher A Lane; Thomas D Parker; Ashvini Keshavan; Sarah M Buchanan; Heidi Murray-Smith; David M Cash; William Coath; Andrew Wong; Nick C Fox; Sebastian J Crutch; Marcus Richards; Jonathan M Schott Journal: J Neurol Neurosurg Psychiatry Date: 2021-05-25 Impact factor: 10.154